Treatment of severe forms of paracoccidioidomycosis: Is there a role for corticosteroids?

Medical Mycology

Volumn 50, Issue 6, 2012, Pages 641-648

  Benard, Gil ^a   Campos, Aléia F ^a   Netto, Lucas C ^a   Gonçalves, Luiz G ^a   MacHado, Luis R ^a   Mimicos, Evanthia V ^a   França, Francisco O S ^a   Gryschek, Ronaldo C B ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adjunct therapy; Corticosteroids; Paracoccidioidomycosis; Paradoxical response; Treatment

Indexed keywords

COTRIMOXAZOLE; DEXAMETHASONE; HYDROCORTISONE; PREDNISONE; SULFADIAZINE; FLUCONAZOLE;

ABDOMINAL MASS; ADULT; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HUMAN; INFLAMMATION; LARYNX STENOSIS; MALE; REVIEW; SOUTH AMERICAN BLASTOMYCOSIS; SYMPTOM; TREATMENT OUTCOME; ABDOMINAL PAIN; ADJUVANT THERAPY; ANTIBODY TITER; ANTIMICROBIAL THERAPY; ARTICLE; CEREBELLUM INJURY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; COUGHING; COUNTER IMMUNOELECTROPHORESIS; DYSPHAGIA; FEVER; GRANULOMATOUS INFLAMMATION; HOARSENESS; LARYNGEAL BIOPSY; LARYNGOSCOPY; LARYNX PAIN; NIGHT SWEAT; PHYSICAL EXAMINATION; SKIN DEFECT; SPUTUM SMEAR; THORAX RADIOGRAPHY; WEIGHT REDUCTION;

ADRENAL CORTEX HORMONES; ADULT; ANTIFUNGAL AGENTS; BIOPSY; BRAIN; HUMANS; LARYNGOSTENOSIS; LARYNX; MALE; MIDDLE AGED; PARACOCCIDIOIDES; PARACOCCIDIOIDOMYCOSIS; RISK ASSESSMENT; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

PARACOCCIDIOIDES BRASILIENSIS;

EID: 84863933905     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2011.654135     Document Type: Review

References (37)

1. McGowan JE Jr, Chesney PJ, Crossley KB, LaForce FM. Guidelines for the use of systemic glucocorticosteroids in the management of selected infections. J Infect Dis 1992; 165: 1-13.
2. Naafs B. Treatment duration of reversal reaction: A reappraisal: Back to the past. Lepr Rev 2003; 74: 328-336.
3. Evans DJ. The use of adjunctive corticosteroids in the treatment of pericardial, pleural and meningeal tuberculosis: Do they improve outcome? Respir Med 2008; 102: 793-800.
4. Smego RA, Ahmed NA. Systematic review of the adjunctive use of systemic corticosteroids for pulmonary tuberculosis. Int J Tuberc Lung Dis 2003; 7: 208-213.
5. Nemir RL, Cardona J, Locoius A, David M. Prednisone therapy as an adjunct in the treatment of lymph node-Bronchial tuberculosis in childhood: A double-Blind study. Am Rev Respir Dis 1963; 88: 189-198.
6. Mottin D, Denis M, Dombret H, e t al . Role for steroids in treatment of Pneumocystis carinii pneumonia in AIDS. Lancet 1987; 2: 519.
7. Wheat LJ, Freifeld AG, Kleiman MB, et al . Clinical practice guidelines for the management of patients with histoplasmosis. Clin Infect Dis 2007; 45: 807-825.
8. Perfect JR, Dismukes WE, Dromer F, et al . Clinical practice guidelines for the management of cryptococcal diseases. Clin Infect Dis 2010; 50: 291-322.
9. Galgiani JN, Ampel NM, Catanzaro A, e t al . Practice guideline for the treatment of coccidioidomycosis. Clin Infect Dis 2000; 30: 658-661.
10. Chapman SW, Dismukes WE, Proia LA, e t al . Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 1801-1812.
11. Almeida SM Central nervous system paracoccidioidomycosis: An overview. Braz J Infect Dis 2005; 9: 126-133.
12. Pedroso VS, Vilela MC, Pedroso ER, Teixeira AL. Paracoccidioidomycosis compromising the central nervous system: A systematic review of the literature. Rev Soc Bras Med Trop 2009; 42: 691-697.
13. Yasuda MA. Pharmacological management of paracoccidioidomycosis. Expert Opin Pharmacother 2005; 6: 385-397.
14. Shikanai-Yasuda MA, Telles Filho Fde Q, Mendes RP, Colombo AL, Moretti ML. Guideline in paracoccidioidomycosis. Rev Soc Bras Med Trop 2006; 39: 297-310.
15. Colli BO, Assirati J ú nior JA, Machado HR et al . Intramedullary spinal cord paracoccidioidomycosis. Report of two cases. Arq Neuropsiquiatr 1996; 54: 466-473.
16. Do Valle AC, Skacel M, Costa RL, e t al . A case report of intraspinal paracoccidioidomycosis. Rev Inst Med Trop Sao Paulo 1998; 40: 203-207.
17. Mendes RP. The gamut of clinical manifestations. In: Franco M, Lacaz CS, Restrepo-Moreno A, Del-Negro G (eds). Paracoccidioidomycosis . Boca Raton, FL: CRC Press, 1994: 233-258.
18. Da Silva CE, Cordeiro AF, Gollner AM, e t al . Paracoccidioidomycosis of the central nervous system: Case report. Arq Neuropsiquiatr 2000; 58: 741-747.
19. Gryschek RCB, Pereira RM, Kono A, et al . Paradoxical reaction to treatment in 2 patients with severe acute paracoccidioidomycosis: A previously unreported complication and its anagement with corticosteroids. Clin Infect Dis 2010; 50: 56-58.
20. Del Negro GM, Pereira CN, Andrade HF, e t al . Evaluation of tests for antibody response in the follow-Up of patients with acute and chronic forms of paracoccidioidomycosis. J Med Microbiol 2000; 49: 37-46.
21. Restrepo A, Benard G, de Castro CC, Agudelo CA, Tob ón AM Pulmonary paracoccidioidomycosis Semin Respir Crit Care Med 2008; 29: 182-197.
22. Tob ón AM, Agudelo CA, Osorio ML, et al . Residual pulmonary abnormalities in adult patients with chronic paracoccidioidomycosis: Prolonged follow-Up after itraconazole therapy. Clin Infect Dis 2003; 37: 898-904.
23. Tuder RM, el Ibrahim R, Godoy CE, De Brito T. Pathology of the human pulmonary paracoccidioidomycosis. Mycopathologia 1985; 92: 179-188.
24. Teixeira F, Gayotto LC, De Brito T. Morphological patterns of the liver in South American blastomycosis. Histopathology 1978; 2: 231-237.
25. Trindade MA, Benard G, Ura S, et al . Granulomatous reactivation during the course of a leprosy infection: Reaction or relapse? PLoS Negl Trop Dis 2010; 21 (4): E921.
26. Morato-Fernandez RN, Beraldo PS, Masini M, Costa PH. Paracoccidioidomycosis of intramedullar and cerebral localization. Arq Neuropsiquiatr 1991; 49: 192-197.
27. N óbrega JPS and Fran ç a AS. Neuroparacoccidioidomycosis. In: Franco M, Lacaz CS, Restrepo-Moreno A. Del-Negro G (eds). Paracoccidioidomycosis . Boca Raton, FL: CRC Press, 1994: 321-330.
28. Fagundes-Pereyra WJ, Carvalho GT, G óes AM, das Chagas Lima e Silva F, de Sousa AA. Central nervous system paracoccidioidomycosis: Analysis of 13 cases. Arq Neuropsiquiatria 2006; 64: 269-276.
29. Paniago AM, de Oliveira PA, Aguiar ES, e t al . Neuroparacoccidioidomycosis: Analysis of 13 cases observed in an endemic area in Brazil. Trans R Soc Trop Med Hyg 2007; 101: 414-420.
30. De Almeida SM, Queiroz-Telles F, Teive HA, Ribeiro CE, Werneck LC. Central nervous system paracoccidioidomycosis: Clinical features and laboratorial findings. J Infect 2004; 48: 193-198.
31. Francesconi F, Silva MTT, Costa RLB, et al . Long term outcome of neuroparacoccidioidomycosis treatment. Rev Soc Bras Med Trop 2011; 44: 22-25.
32. Filho JM, Miranda JL, Teixeira GA. Considerations on South American blastomycosis: Outcome, therapeutic results and associated diseases in 394 consecutive cases [in Spanish]. O Hospital 1961; 60: 374-412.
33. Do Valle AC, Aprigliano Filho F, Moreira JS, Wanke B. Clinical and endoscopic findings in the mucosae of the upper respiratory and digestive tracts in post-Treatment follow-Up of paracoccidioidomycosis patients. Rev Inst Med Trop S ã o Paulo 1995; 37: 407-413.
34. McGee S, Hirschmann J. Use of corticosteroids in treating infectious diseases. Arch Intern Med 2008; 168: 1034-1046.
35. Mayanja-Kizza H, Jones-Lopez E, Okwera A, e t al . Immunoadjuvant prednisolone therapy for HIV-Associated tuberculosis: A phase 2 clinical trial in Uganda. J Infect Dis 2005; 191: 856-865.
36. Meijvis SC, Hardeman H, Remmelts HH, e t al . Dexamethasone and length of hospital stay in patients with community-Acquired pneumonia: A randomised, double-Blind, placebo-Controlled trial. Lancet 2011; 377: 2023-2030.
37. Naranjo TW, Lopera DE, Diaz-Granados LR, e t al . Combined itraconazole-Pentoxifylline treatment promptly reduces lung fibrosis induced by chronic pulmonary paracoccidioidomycosis in mice. Pulm Pharvmacol Ther 2011; 24: 81-91.